Olstein Capital Management L.P. Cuts Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Olstein Capital Management L.P. decreased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 25.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,000 shares of the company’s stock after selling 9,000 shares during the quarter. Olstein Capital Management L.P. owned 0.05% of Prestige Consumer Healthcare worth $2,030,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Martingale Asset Management L P boosted its position in Prestige Consumer Healthcare by 0.4% in the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock valued at $2,666,000 after buying an additional 140 shares during the period. Horizon Kinetics Asset Management LLC boosted its holdings in Prestige Consumer Healthcare by 4.8% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after purchasing an additional 150 shares during the period. Evergreen Capital Management LLC grew its stake in Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after purchasing an additional 160 shares in the last quarter. OLD National Bancorp IN grew its stake in Prestige Consumer Healthcare by 4.4% during the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock worth $287,000 after purchasing an additional 168 shares in the last quarter. Finally, Huntington National Bank increased its holdings in Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after purchasing an additional 181 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analysts Set New Price Targets

PBH has been the subject of several recent research reports. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, DA Davidson reaffirmed a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $85.25.

Insider Activity

In other news, CEO Ronald M. Lombardi sold 10,875 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the transaction, the chief executive officer now directly owns 320,952 shares of the company’s stock, valued at $26,510,635.20. The trade was a 3.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider William P’pool sold 8,987 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total transaction of $735,585.95. Following the sale, the insider now owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. This represents a 30.94 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 38,810 shares of company stock valued at $3,187,300. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock opened at $76.79 on Friday. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a 52 week low of $60.00 and a 52 week high of $86.36. The firm’s 50 day moving average is $80.08 and its two-hundred day moving average is $74.88. The firm has a market capitalization of $3.79 billion, a P/E ratio of 18.68, a P/E/G ratio of 2.17 and a beta of 0.51.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same period last year, the firm posted $1.07 EPS. The company’s revenue was down .9% on a year-over-year basis. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.46 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.